AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.21), $0.05 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $45.2 million versus the consensus estimate of $44.21 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.